Clinical trial

Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease

NCT06003608

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention Fluid biopsy capsule Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Levodopa-Carbidopa Immediate Release Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease

Design: OBSERVATIONAL · Status: ACTIVE NOT RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2024-02-19

PhaseN/A

Conditions

Parkinson Diseaseverified · MONDO: Parkinson disease

Interventions

Fluid biopsy capsuleDEVICE

Levodopa-Carbidopa Immediate ReleaseDRUG

Sponsors & collaborators

Nimble Science Ltd.lead sponsor

MRM Health NVcollaborator

Mapped research locations

CalgaryAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06003608 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.